Italy
Tuberculosis profile
Population  2013 61 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.31 (0.31–0.31) 0.51 (0.5–0.51)
Mortality (HIV+TB only) <0.01 (<0.01–0.014) 0.01 (0.01–0.02)
Prevalence  (includes HIV+TB) 4.1 (1.5–7.9) 6.7 (2.5–13)
Incidence  (includes HIV+TB) 3.5 (3.3–3.9) 5.7 (5.5–6.4)
Incidence (HIV+TB only) 0.089 (0.085–0.1) 0.15 (0.14–0.16)
Case detection, all forms (%) 87 (77–91)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 2.6 (1.4–4.6) 8.8 (4.6–15)
MDR-TB cases among notified pulmonary
TB cases
62 (32–110) 12 (6–20)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 947   0
Pulmonary, clinically diagnosed 1 384   0
Extrapulmonary 688   0
       
Total new and relapse 3 019    
Previously treated, excluding relapses 134    
Total cases notified 3 153    
Among 2 506 new and relapse cases:
124 (5%) cases aged under 15 years; male:female ratio: 1.3
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 663 (70%) 168 (125%) 2 350
Laboratory-confirmed RR-/MDR-TB cases     97
Patients started on MDR-TB treatment      
TB/HIV 2013 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New cases registered in 2012  
Previously treated cases registered in 2012  
HIV-positive TB cases, all types, registered in 2012  
RR-/MDR-TB cases started on second-line treatment in 2011  
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-07-07 Data: www.who.int/tb/data